Liver Disease Clinical Trials in Virginia

12 recruiting studies across 1 city

Browse by City

All Trials in Virginia

Phase

Trial	Phase	Sponsor	Dist.
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors	Phase 2	DualityBio Inc.	<1 mi
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )	Phase 3	Inventiva Pharma	17 mi
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)	Phase 3	Eli Lilly and Company	17 mi
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH	Phase 3	Akero Therapeutics, Inc	17 mi
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	Phase 3	Children's Oncology Group	17 mi
The Vanguard Study: Testing a New Way to Screen for Cancer	N/A	National Cancer Institute (NCI)	17 mi
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma	Phase 2	Coherus Oncology, Inc.	17 mi
Multi-analyte Blood Test Clinical Trial	—	Helio Genomics	17 mi
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis	Phase 3	Gilead Sciences	27 mi
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis	Phase 3	Boehringer Ingelheim	27 mi
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis	Phase 2	Mirum Pharmaceuticals, Inc.	27 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis	Phase 2	Genentech, Inc.	27 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.